Prot #DEK-DKK1-P102: A Five Part, Phase 1, Study of DKN-01 in Combination with Paclitaxel; Part A: A Dose-Escalation Study in Patients with Relapsed or Refractory Esophageal Cancer or Gastro-esophageal Junction Tumors; Part B: An Expansion Cohort in Patie

Project: Research project

Project Details

StatusActive
Effective start/end date5/31/175/31/23

Funding

  • Novella Clinical, LLC (Prot #DEK-DKK1-P102)
  • Leap Therapeutics, Inc. (Prot #DEK-DKK1-P102)